miR-181a negatively regulates NF-κB signaling and affects activated B-cell–like diffuse large B-cell lymphoma pathogenesis
Open Access
- 9 June 2016
- journal article
- Published by American Society of Hematology in Blood
- Vol. 127 (23) , 2856-2866
Abstract
Key Points: miR-181a regulates the NF-κB signaling pathway by targeting CARD11, NFKBIA, NFKB1, RELA/P65, and REL. miR-181a represses NF-κB signaling and decreases cell proliferation and survival most potently in the NF-κB dependent ABC-DLBCL subgroup.Keywords
This publication has 53 references indexed in Scilit:
- MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblastsJournal of Inflammation, 2013
- The MicroRNA miR-181 Is a Critical Cellular Metabolic Rheostat Essential for NKT Cell Ontogenesis and Lymphocyte Development and HomeostasisImmunity, 2013
- MicroRNAs in NF- B signalingJournal of Molecular Cell Biology, 2011
- PI3 Kinase Signals BCR-Dependent Mature B Cell SurvivalCell, 2009
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- miR-181b negatively regulates activation-induced cytidine deaminase in B cellsJournal of Experimental Medicine, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin ChainCell, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000